Get notified when NEOG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Securities Litigation (new) — New putative class actions filed against the company and executives alleging false statements about the 3M integration and offering materials.
- Product Recall (new) — Voluntary recall of Vet HyCoat due to microbial contamination, with potential refunds and litigation.
- Supplier Quality Issues (new) — Third-party supplier quality and manufacturing issues hurt Animal Safety revenue, partly tied to tariff-driven transitions.
Neogen swings to near-breakeven after $1.06B goodwill charge, sells Genomics to Zoetis
Filed July 30, 2026 · Period ending May 31, 2026 · Compared to 10-K Jul 30, 2025 · ~2 min read
Key Changes
-
high
Subsequent event: In June 2026, the Company made $20.0 million of prepayments on its Term Loan. Based on this prepayment, there are no additional required principal payments for the Term Loan until the first quarter of fiscal year 2029…
Notes: Subsequent Events verify on EDGAR → -
high
Net loss narrowed to $7.9M from $1.1B as the prior year's $1.06B goodwill impairment did not recur; operating loss fell 98% to $21.6M.
MD&A: Operating Loss verify on EDGAR → -
high
Agreed to sell Genomics business to Zoetis for $160M, closing expected in first half of fiscal 2027, pending regulatory reviews in Australia and New Zealand.
Business: Genomics divestiture verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Partner
Trade NEOG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 4, 2026 · How we verify